PolymarketVerfügbarkeit prüfenKein KYC2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite WahrscheinlichkeitDecember 63%+2.0pt
Marktqualitat
46 / 100
Niedrige Qualität24h-Volumen
0 €
Liquidität
996,1 €
Niedrige LiquiditätGeld / Brief
27.0% / 29.0%
Spread
2.0 pt
Enger SpreadMarktdaten
Aktualisiert vor 22 Minuten
23. Juni 26, 2:1331. Dez. 26, 23:59
Trends
Nur virtuelles Guthaben – kein echtes GeldKeine Finanzberatung
Gewähltes Ergebnis
December63%
Volumentrend
$283. Juli17T Daten25. Juli
Verwandte Märkte
Will the NIH indirect cost cap stick?
878,8 €Ja: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETSWill George W Bush outlive Obama?
453,4 €Ja: 12.3%MANIFOLD MARKETS
MANIFOLD MARKETSWill a majority of states legalize psychedelics by 2033?
439,4 €Ja: 11.7%MANIFOLD MARKETS
MANIFOLD MARKETS
Who will Trump announce as next FDA commissioner?
39,4 €No announcement by December 31: 41%POLYMARKET
POLYMARKET
What will the average number of measles cases be during Trump's term?
19,6 €At least 4500: 43%
KALSHI
KALSHI
Will a bill curbing pharmaceutical monopolies become law?
0 €Ja: 9%KALSHI
KALSHIIn diesen Themen aktiv
Verwandte Nachrichten
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsRegeln
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.